RetractedArticleHeliyon2023

Development of a highly sensitive chemiluminescence immunoassay using a novel signal-enhanced detection system for quantitation of durvalumab, an immune-checkpoint inhibitor monoclonal antibody used for immunotherapy of lung cancer.

Ibrahim A Darwish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.